| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |